The trademark application ELLIPSES was filed by Ellipses Pharma Ltd, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on October 27, 2021, and it was registered by office on February 3, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Veterinary preparations
Dietetic preparations for medical purposes
Dietetic foods for use in clinical nutrition
Food supplements
Nutraceuticals for therapeutic or medical purposes
Medicated food supplements
Biological preparations for the treatment of cancer
Anti-cancer preparations
Anti-cancer drugs
Compounds for treating cancer
Biopharmaceuticals for the treatment of cancer
Anti-cancer preparations of chemical origin
Anti-cancer preparations of plant origin
Anti-cancer preparations of microbial origin
Pharmaceutical preparations for the treatment of cancer
Anti-cancer preparations from hormones and antagonists
Pharmaceutical preparations and substances for the prevention of cancer
Pharmaceutical preparations and substances for the treatment of cancer
All of the aforesaid for use in oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer
Pharmaceutical preparations and veterinary preparations.
The mark was filed in class 42 with following description of goods:
Medical and pharmacological research services
Biological research, clinical research and medical research
Providing a research and development network for drug and pharmaceutical development
Providing a network for the design, development and testing of drugs and pharmaceuticals
Providing scientific and technological services and research, analysis, and design relating thereto
Design, development and testing of drugs and pharmaceuticals for the treatment and/or prevention of cancer
Laboratory research into new drugs and pharmaceutical products
Pharmaceutical drug development services
Research relating into medicines
Consultancy services relating to scientific and medical research
Expert advice relating to drug development
Laboratory analysis
Computer hardware and software design and development in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer
Computer network services in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer
Software hosting services in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer
Software as a service in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer
Information Technology (IT) consultancy, advisory and information services relating to a network of medical research professionals
Scientific advisory services
Scientific research projects and studies
Conducting clinical trials
Clinical research
Clinical research for cancer treatments and pharmaceuticals
Providing an online network for clinical trials
Conducting and collating a research network for treatment, cure and/or prevention of cancer